Add Yahoo as a preferred source to see more of our stories on Google. Treg cells have been thrust into the limelight thanks to the Nobel Prize-winning work of a team of researchers from the U.S. and ...
Oral presentations highlight first-in-human data for TRX103 and novel CAR-Tr1 Treg therapy TRX319. Data underscore potential ...
CAR-T cell therapy works well in blood cancers, but many patients still become resistant. A key reason is the presence of CAR ...
Cellenkos®, Inc., a clinical-stage biotechnology company, developing allogeneic, tissue-targeted regulatory T cell (Treg) ...
Most people swallow corn, soy, and wheat thousands of times without thinking about it. New work from Stanford University ...
Kincell Bio, a leading U.S. cell therapy contract development and manufacturing organization (CDMO), today announced a new collaboration with RegCell, a biotechnology company developing first‑in‑class ...
During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and viruses from self-antigens that are expressed by cells of the body. If not, the ...
Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate ...
COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist (GLP-1RA), designed to deliver a multi-targeted immunomodulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results